These results demonstrate the potent antimicrobial activity of microencapsulated carvacrol against this bacterial strain, which is highly significant given that the S. aureus pathogen has developed resistance mechanisms to the vast majority of antimicrobial drugs used in treatment, namely the beta-lactam, glycopeptide, and oxazolidinone drugs [ 56 ].
← all excerpts
Study of the Resistance of <i>Staphylococcus aureus</i> Biofilm, Biofilm-Detached Cells, and Planktonic Cells to Microencapsulated Carvacrol Used Alone or Combined with Low-pH Treatment.
1
—
—